22nd Century Group (NASDAQ:XXII) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of 22nd Century Group (NASDAQ:XXII) in a research note published on Wednesday morning. The firm issued a sell rating on the biotechnology company’s stock.

22nd Century Group Stock Performance

Shares of NASDAQ:XXII opened at $0.09 on Wednesday. The firm has a market cap of $4.27 million, a PE ratio of 0.00 and a beta of 1.45. 22nd Century Group has a 12-month low of $0.09 and a 12-month high of $5.69. The company has a quick ratio of 0.67, a current ratio of 1.09 and a debt-to-equity ratio of 1.59. The company’s 50 day moving average price is $0.18 and its two-hundred day moving average price is $0.62.

22nd Century Group (NASDAQ:XXII) last released its earnings results on Tuesday, November 12th. The biotechnology company reported ($0.54) earnings per share for the quarter. The business had revenue of $5.95 million for the quarter. 22nd Century Group had a negative return on equity of 380.39% and a negative net margin of 144.09%.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in 22nd Century Group stock. Anson Funds Management LP acquired a new position in shares of 22nd Century Group, Inc. (NASDAQ:XXII) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned 6.77% of 22nd Century Group as of its most recent SEC filing. 18.06% of the stock is currently owned by institutional investors.

22nd Century Group Company Profile

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.